STAGAN: An approach for improve the stability of molecular graph generation based on generative adversarial networks

被引:2
作者
Zou, Jinping [1 ,2 ]
Yu, Jialin [1 ]
Hu, Pengwei [1 ]
Zhao, Long [1 ,2 ]
Shi, Shaoping [1 ,2 ]
机构
[1] Nanchang Univ, Sch Math & Comp Sci, Dept Math, Nanchang 330031, Peoples R China
[2] Nanchang Univ, Inst Math & Interdisciplinary Sci, Nanchang 330031, Peoples R China
基金
中国国家自然科学基金;
关键词
Generative adversarial networks; Model collapse; Graph convolutional network; Molecular graph generation; Deep learning; DRUG DISCOVERY; DESIGN; COMBINATORIAL; LIBRARIES; ART;
D O I
10.1016/j.compbiomed.2023.107691
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
With the wide application of deep learning in Drug Discovery, deep generative model has shown its advantages in drug molecular generation. Generative adversarial networks can be used to learn the internal structure of molecules, but the training process may be unstable, such as gradient disappearance and model collapse, which may lead to the generation of molecules that do not conform to chemical rules or a single style. In this paper, a novel method called STAGAN was proposed to solve the difficulty of model training, by adding a new gradient penalty term in the discriminator and designing a parallel layer of batch normalization used in generator. As an illustration of method, STAGAN generated higher valid and unique molecules than previous models in training datasets from QM9 and ZINC-250K. This indicates that the proposed method can effectively solve the instability problem in the model training process, and can provide more instructive guidance for the further study of molecular graph generation.
引用
收藏
页数:9
相关论文
共 53 条
[1]  
[Anonymous], 2014, P DEEP LEARN WORKSH
[2]  
Arjovsky M, 2017, PR MACH LEARN RES, V70
[3]   Integration of virtual and high-throughput screening [J].
Bajorath, F .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (11) :882-894
[4]   The properties of known drugs .1. Molecular frameworks [J].
Bemis, GW ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (15) :2887-2893
[5]   Automated design of ligands to polypharmacological profiles [J].
Besnard, Jeremy ;
Ruda, Gian Filippo ;
Setola, Vincent ;
Abecassis, Keren ;
Rodriguiz, Ramona M. ;
Huang, Xi-Ping ;
Norval, Suzanne ;
Sassano, Maria F. ;
Shin, Antony I. ;
Webster, Lauren A. ;
Simeons, Frederick R. C. ;
Stojanovski, Laste ;
Prat, Annik ;
Seidah, Nabil G. ;
Constam, Daniel B. ;
Bickerton, G. Richard ;
Read, Kevin D. ;
Wetsel, William C. ;
Gilbert, Ian H. ;
Roth, Bryan L. ;
Hopkins, Andrew L. .
NATURE, 2012, 492 (7428) :215-+
[6]  
Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/nchem.1243, 10.1038/NCHEM.1243]
[7]  
Bohacek RS, 1996, MED RES REV, V16, P3, DOI 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO
[8]  
2-6
[9]   THE COMPUTER-PROGRAM LUDI - A NEW METHOD FOR THE DENOVO DESIGN OF ENZYME-INHIBITORS [J].
BOHM, HJ .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1992, 6 (01) :61-78
[10]   Molecular design in drug discovery: a comprehensive review of deep generative models [J].
Cheng, Yu ;
Gong, Yongshun ;
Liu, Yuansheng ;
Song, Bosheng ;
Zou, Quan .
BRIEFINGS IN BIOINFORMATICS, 2021, 22 (06)